Q2 2017 Holdings
Filed 2017-08-14 | 8 holdings | $105.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $104.2M | 383,858 | 99.1% |
| Abbvie Inc.(ABBV) | COM | 00287Y109 | $725.0K | 10,000 | 0.7% |
| Bioverativ Inc | COM | 09075R100 | $70.1K | 1,165,000 | 0.1% |
| Medicines Co | COM | 584688105 | $66.6K | 1,752,000 | 0.1% |
| Innoviva Inc(INVA) | COM | 45781M101 | $44.7K | 3,490,705 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $9.5K | 1,025,000 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $2.2K | 339,180 | 0.0% |
| Apricus Biosciences Inc | COM NEW | 03832V307 | $1.6K | 1,447,906 | 0.0% |